The answer is a little more complicated than yes or no
Medicare Part D patients who meet the Medicare GLP-1 Bridge Clinical Criteria and other CMS eligibility requirements may be able to access Foundayo (orforglipron) or Zepbound (tirzepatide) for weight management under the Medicare GLP-1 Bridge program for $50 per month
Those with limited dexterity, vision impairment, or lack of access to sterile supplies may benefit from pre-filled injection pens or provider-administered doses
Additionally, a variety of other meningococcal outer membrane proteins fulfill the role of minor adhesins, such as NadA, NhhA, App, MspA, and HrpA of the meningococcal TPS system 1 HrpA/HrpB (Hadi et al., 2001
De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction
Maybe availability issues forced a switch